These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 29566148)

  • 21. C1qTNF-related protein 1 attenuates doxorubicin-induced cardiac injury via activation of AKT.
    Chen H; Gao L; Huang Z; Liu Y; Guo S; Xing J; Meng Z; Liang C; Li Y; Yao R; Li L; Zhang Y; Gu H; Liu Y
    Life Sci; 2018 Aug; 207():492-498. PubMed ID: 29964055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of Mrp1 Potentiates Doxorubicin-Induced Cytotoxicity in Neonatal Mouse Cardiomyocytes and Cardiac Fibroblasts.
    Zhang W; St Clair D; Butterfield A; Vore M
    Toxicol Sci; 2016 May; 151(1):44-56. PubMed ID: 26822305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salidroside Attenuates Doxorubicin-Induced Cardiac Dysfunction Partially Through Activation of QKI/FoxO1 Pathway.
    Yan F; Liu R; Zhuang X; Li R; Shi H; Gao X
    J Cardiovasc Transl Res; 2021 Apr; 14(2):355-364. PubMed ID: 32671648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diverging effects of enalapril or eplerenone in primary prevention against doxorubicin-induced cardiotoxicity.
    Hullin R; Métrich M; Sarre A; Basquin D; Maillard M; Regamey J; Martin D
    Cardiovasc Res; 2018 Feb; 114(2):272-281. PubMed ID: 29016737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pea (Pisum sativum) peel extract attenuates DOX-induced oxidative myocardial injury.
    Abdelghffar EA; Obaid WA; Elgamal AM; Daoud R; Sobeh M; El Raey MA
    Biomed Pharmacother; 2021 Nov; 143():112120. PubMed ID: 34649330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex-related differences in delayed doxorubicin-induced cardiac dysfunction in C57BL/6 mice.
    Abdelgawad IY; George B; Grant MKO; Huang Y; Shan Y; Huang RS; Zordoky BN
    Arch Toxicol; 2024 Apr; 98(4):1191-1208. PubMed ID: 38244039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardioprotective effects of granulocyte colony-stimulating factor in angiotensin II-induced cardiac remodelling.
    Jia N; Dong P; Huang Q; Jin W; Zhang J; Dai Q; Liu S
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):262-6. PubMed ID: 18785976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MMP inhibitors attenuate doxorubicin cardiotoxicity by preventing intracellular and extracellular matrix remodelling.
    Chan BYH; Roczkowsky A; Cho WJ; Poirier M; Sergi C; Keschrumrus V; Churko JM; Granzier H; Schulz R
    Cardiovasc Res; 2021 Jan; 117(1):188-200. PubMed ID: 31995179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin-(1-7) reduces doxorubicin-induced cardiac dysfunction in male and female Sprague-Dawley rats through antioxidant mechanisms.
    Rahimi O; Kirby J; Varagic J; Westwood B; Tallant EA; Gallagher PE
    Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H883-H894. PubMed ID: 32083974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resistance training improves cardiac function and cardiovascular autonomic control in doxorubicin-induced cardiotoxicity.
    Feitosa LAS; Carvalho JDS; Dantas CO; de Souza DS; de Vasconcelos CML; Miguel-Dos-Santos R; Lauton-Santos S; Quíntans-Júnior LJ; Santos MRV; de Santana-Filho VJ; Barreto AS
    Cardiovasc Toxicol; 2021 May; 21(5):365-374. PubMed ID: 33387253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resveratrol protects against doxorubicin-induced cardiotoxicity by attenuating ferroptosis through modulating the MAPK signaling pathway.
    Chen L; Sun X; Wang Z; Chen M; He Y; Zhang H; Han D; Zheng L
    Toxicol Appl Pharmacol; 2024 Jan; 482():116794. PubMed ID: 38142782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasmatic and chamber-specific modulation of cardiac microRNAs in an acute model of DOX-induced cardiotoxicity.
    Gioffré S; Ricci V; Vavassori C; Ruggeri C; Chiesa M; Alfieri I; Zorzan S; Buzzetti M; Milano G; Scopece A; Castiglioni L; Sironi L; Pompilio G; Colombo GI; D'Alessandra Y
    Biomed Pharmacother; 2019 Feb; 110():1-8. PubMed ID: 30453253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitochondrial ROS-induced ERK1/2 activation and HSF2-mediated AT
    Huang CY; Chen JY; Kuo CH; Pai PY; Ho TJ; Chen TS; Tsai FJ; Padma VV; Kuo WW; Huang CY
    J Cell Physiol; 2018 Jan; 233(1):463-475. PubMed ID: 28295305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardioprotective effects of curcumin and nebivolol against doxorubicin-induced cardiac toxicity in rats.
    Imbaby S; Ewais M; Essawy S; Farag N
    Hum Exp Toxicol; 2014 Aug; 33(8):800-13. PubMed ID: 24648241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain-derived neurotrophic factor attenuates doxorubicin-induced cardiac dysfunction through activating Akt signalling in rats.
    Hang P; Zhao J; Sun L; Li M; Han Y; Du Z; Li Y
    J Cell Mol Med; 2017 Apr; 21(4):685-696. PubMed ID: 28098423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Resistance Exercise Training on Doxorubicin-Induced Cardiotoxicity.
    Pfannenstiel K; Hayward R
    J Cardiovasc Pharmacol; 2018 Jun; 71(6):332-339. PubMed ID: 29521673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Juvenile exposure to doxorubicin alters the cardiovascular response to adult-onset psychosocial stress in mice.
    Grant MKO; Razzoli M; Abdelgawad IY; Mansk R; Seelig D; Bartolomucci A; Zordoky BN
    Stress; 2022 Jan; 25(1):291-304. PubMed ID: 35942624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of p38 MAPK Inhibitor on angiotensin II-dependent hypertension, organ damage, and superoxide anion production.
    Bao W; Behm DJ; Nerurkar SS; Ao Z; Bentley R; Mirabile RC; Johns DG; Woods TN; Doe CP; Coatney RW; Ohlstein JF; Douglas SA; Willette RN; Yue TL
    J Cardiovasc Pharmacol; 2007 Jun; 49(6):362-8. PubMed ID: 17577100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphoinositide 3-Kinase Gamma Inhibition Protects From Anthracycline Cardiotoxicity and Reduces Tumor Growth.
    Li M; Sala V; De Santis MC; Cimino J; Cappello P; Pianca N; Di Bona A; Margaria JP; Martini M; Lazzarini E; Pirozzi F; Rossi L; Franco I; Bornbaum J; Heger J; Rohrbach S; Perino A; Tocchetti CG; Lima BHF; Teixeira MM; Porporato PE; Schulz R; Angelini A; Sandri M; Ameri P; Sciarretta S; Lima-Júnior RCP; Mongillo M; Zaglia T; Morello F; Novelli F; Hirsch E; Ghigo A
    Circulation; 2018 Aug; 138(7):696-711. PubMed ID: 29348263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Qingda granule attenuates angiotensin II-induced cardiac hypertrophy and apoptosis and modulates the PI3K/AKT pathway.
    Cheng Y; Shen A; Wu X; Shen Z; Chen X; Li J; Liu L; Lin X; Wu M; Chen Y; Chu J; Peng J
    Biomed Pharmacother; 2021 Jan; 133():111022. PubMed ID: 33378940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.